Labiotech.eu

News and Trends 26 May 2016

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic test that could help guide the treatment of breast cancer. Now, Qiagen has partnered with […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

TxCell is restarting its trial for Ovasave, an autologous T-cell therapy, with a new manufacturing partner. This therapy is targeting Crohn’s disease which does not respond to current treatments. TxCell is based in Sophia-Antipolis (France) and is developing immunotherapies based on a type of T-cells that have anti-inflammatory properties – regulatory T-lymphocytes (Tregs). Its most advanced programme is in refractory Crohn’s […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 26 May 2016

GSK teams up with US Money to found new Biotech

GSK and Avalon Ventures are having success with the Biotechs created under their collaboration. Sitari Pharmaceuticals and Silarus Therapeutics have achieved their first milestones, and there’s a 8th Biotech in the making. As part of its innovation hunting in the US, English big Pharma GSK had struck a collaboration with Avalon Ventures and formed an ‘undercover incubator’ of sorts. […]

May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 24 May 2016

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

Bavarian Nordic will receive €90M from the US’ BARDA for its nonreplicating smallpox vaccine – which can be administered to people with conditions like HIV. Bavarian Nordic is one of the Copenhagen-based Biotechs you need to know which is developing cancer immunotherapies and vaccines against infectious diseases. Its infectious disease programme is based on their vaccine technology which uses an […]

May 24, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 May 2016

To Be – or Not To Be, a Virtual Biotech?

Many new biotechs start off as virtual companies. But at each stage of development, you always end up asking whether you should stay virtual or build your own in-house wet labs. What are the pros and cons of being virtual? And is there a more pragmatic “semi-virtual” approach? Pros and Cons of being Virtual Biotechs […]

May 23, 2016 - 5 minutesmins - By Dani Bancroft

News and Trends 23 May 2016

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Yes, everyone is talking about how Germany’s Pharma giant Bayer has made a $62 billion offer for the infamous chemicals conglomerate Monsanto. And not many like it. Bayer’s products mostly consist of human and veterinary pharmaceuticals, consumer healthcare products, agricultural chemicals, biotechnological products, and high value polymers. Monsanto on the other hand is notorious for its agricultural chemicals, GMOs […]

May 23, 2016 - 3 minutesmins - By Dani Bancroft

News and Trends 23 May 2016

Irish NASH drug will also be investigated for Major Lung Diseases

DS Biopharma was already studying one of its bioactive lipids for non-alcoholic steatohepatitis (NASH). The candidate will now also target chronic obstructive pulmonary disease (COPD). Headquartered in Dublin (Ireland), DS Biopharma is working on new medicines for medical unmet needs, such as fibrosis. This development of fibrous tissue can affect the lungs, liver or heart. DS has […]

May 23, 2016 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 23 May 2016

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

Researchers from University of Cambridge and the Wellcome Trust Sanger Institute have discovered that Ebola can still be transmitted through sex and breastfeeding after quarantine – causing ‘flare-ups’ even though the epidemic has ended. Without effective vaccines or treatments for Ebola infection, the 2014’s outbreak in West Africa was contained due to public health measures. These […]

May 23, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 May 2016

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

InnVentis is aiming big in the field of precision medicine. With novel molecular diagnostics and big data, it wants to tackle complicated conditions like Rheumatoid Arthiritis. Just starting out, InnVentis is an Israeli Biotech founded by Thomas Wilckens, a German expert in precision medicine originally from Munich. He and his team decided to move to Israel for financial reasons […]

May 20, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 20 May 2016

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

We like Scandinavia so much we just don’t want to leave, therefore, we’re heading back East again! This time, Gothenburg is our destination. Being the second biggest city in Sweden and having the biggest harbor in the Northern countries (and once the hosting city for the Eurovision Song Contest in 1985) it is also where […]

May 20, 2016 - 2 minutesmins - By Joachim Eeckhout

News and Trends 19 May 2016

DIY Biology catches on with the UK’s first BioHackacthon

The hackathon phenomena is knocking on biology’s door. The first UK Biohackathon will be held at the University of Cambridge in June, to learn and create with SynBio. Hackathons are massively popular events in computer programming, joining people during a short period to create a hands-on project. The concept has now spread to biology – more […]

May 19, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 19 May 2016

FDA approves First ever antibody to target Cancer PD-L1

Roche has received market approval for atezolizumab to treat a common type of bladder cancer. It’s the 3rd checkpoint inhibitor on the market, and the first to target PD-L1. Immuno-oncology is a hype field that promises to revolutionize cancer treatment, with a lot of active research and big deals (like the €600M deal between argenx […]

May 19, 2016 - 2 minutesmins - By Denise Neves Gameiro

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Qiagen partners up for Novel Diagnostic against Breast Cancer

French T-cell Expert restarts trial for Crohn’s after Manufacturing Hiccup

GSK teams up with US Money to found new Biotech

Danish ‘safer’ vaccine for Smallpox gets US order worth €90M

To Be – or Not To Be, a Virtual Biotech?

Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased…

Irish NASH drug will also be investigated for Major Lung Diseases

Even after Quarantine, Ebola still transmitted by Breastfeeding and Sex

This Israel-based Biotech startup is currently raising €17M to enable Precision Medicine

Biotech of the Week: Immunicum, Immuno-oncology made in Sweden

DIY Biology catches on with the UK’s first BioHackacthon

FDA approves First ever antibody to target Cancer PD-L1

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!